204 related articles for article (PubMed ID: 21282426)
1. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
McNeil JC; Hulten KG; Kaplan SL; Mason EO
Antimicrob Agents Chemother; 2011 May; 55(5):2431-3. PubMed ID: 21282426
[TBL] [Abstract][Full Text] [Related]
2. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.
Doudoulakakis A; Spiliopoulou I; Spyridis N; Giormezis N; Kopsidas J; Militsopoulou M; Lebessi E; Tsolia M
J Clin Microbiol; 2017 Aug; 55(8):2529-2537. PubMed ID: 28592549
[TBL] [Abstract][Full Text] [Related]
3. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.
Fritz SA; Hogan PG; Camins BC; Ainsworth AJ; Patrick C; Martin MS; Krauss MJ; Rodriguez M; Burnham CA
Antimicrob Agents Chemother; 2013 Jan; 57(1):559-68. PubMed ID: 23147738
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin resistance among Staphylococcus aureus strains in Israel: implications for empirical treatment of skin and soft tissue infections.
Stein M; Komerska J; Prizade M; Sheinberg B; Tasher D; Somekh E
Int J Infect Dis; 2016 May; 46():18-21. PubMed ID: 26987479
[TBL] [Abstract][Full Text] [Related]
6. Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.
McNeil JC; Hulten KG; Kaplan SL; Mason EO
Antimicrob Agents Chemother; 2014 May; 58(5):2878-83. PubMed ID: 24614375
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant clones of community-associated meticillin-resistant Staphylococcus aureus isolated from Chinese children and the resistance genes to clindamycin and mupirocin.
Wang L; Liu Y; Yang Y; Huang G; Wang C; Deng L; Zheng Y; Fu Z; Li C; Shang Y; Zhao C; Sun M; Li X; Yu S; Yao K; Shen X
J Med Microbiol; 2012 Sep; 61(Pt 9):1240-1247. PubMed ID: 22595913
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.
Shittu AO; Udo EE; Lin J
BMC Infect Dis; 2009 Jan; 9():10. PubMed ID: 19175912
[TBL] [Abstract][Full Text] [Related]
9. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.
Hurdle JG; O'Neill AJ; Mody L; Chopra I; Bradley SF
J Antimicrob Chemother; 2005 Dec; 56(6):1166-8. PubMed ID: 16275681
[TBL] [Abstract][Full Text] [Related]
10. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients.
Shahsavan S; Emaneini M; Noorazar Khoshgnab B; Khoramian B; Asadollahi P; Aligholi M; Jabalameli F; Eslampour MA; Taherikalani M
Burns; 2012 May; 38(3):378-82. PubMed ID: 22040930
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant S. aureus infections among patients in the emergency department.
Moran GJ; Krishnadasan A; Gorwitz RJ; Fosheim GE; McDougal LK; Carey RB; Talan DA;
N Engl J Med; 2006 Aug; 355(7):666-74. PubMed ID: 16914702
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Baek YS; Jeon J; Ahn JW; Song HJ
Int J Dermatol; 2016 Apr; 55(4):e191-7. PubMed ID: 26892888
[TBL] [Abstract][Full Text] [Related]
13. Failure of decolonization in patients with infections due to mupirocin-resistant strains of community-associated methicillin-resistant Staphylococcus aureus.
Graber CJ; Schwartz BS
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):284; author reply 284-5. PubMed ID: 18257694
[No Abstract] [Full Text] [Related]
14. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance.
Udo EE; Jacob LE; Mathew B
J Med Microbiol; 2001 Oct; 50(10):909-915. PubMed ID: 11599741
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.
Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E
BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276
[TBL] [Abstract][Full Text] [Related]
16. A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance.
Udo EE; Al-Sweih N; Noronha BC
J Antimicrob Chemother; 2003 May; 51(5):1283-6. PubMed ID: 12668579
[TBL] [Abstract][Full Text] [Related]
17. Failure to decolonize mupirocin and linezolid resistant MRSA from a patient with necrotizing soft tissue infection.
Rai S; Rani M; Choudhury DD; Singh NP; Gupta A; Manchanda V
J Infect Public Health; 2016; 9(5):667-9. PubMed ID: 26837722
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of mupirocin resistance in Staphylococcus aureus.
Hetem DJ; Bonten MJ
J Hosp Infect; 2013 Dec; 85(4):249-56. PubMed ID: 24144552
[TBL] [Abstract][Full Text] [Related]
19. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus.
Khoshnood S; Heidary M; Asadi A; Soleimani S; Motahar M; Savari M; Saki M; Abdi M
Biomed Pharmacother; 2019 Jan; 109():1809-1818. PubMed ID: 30551435
[TBL] [Abstract][Full Text] [Related]
20. Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals.
Prakash R; Garg A; Arya R; Kumawat RK
Sci Rep; 2023 Jun; 13(1):10171. PubMed ID: 37349503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
